Advanced Cancer
603
90
133
308
Key Insights
Highlights
Success Rate
84% trial completion
Published Results
76 trials with published results (13%)
Research Maturity
308 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
60 terminated out of 603 trials
83.7%
-2.8% vs benchmark
4%
26 trials in Phase 3/4
25%
76 of 308 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 308 completed trials
Clinical Trials (603)
Electroacupuncture for Preventing Chemotherapy-Induced Peripheral Neuropathy in Patients With Advanced Cancer
Effects of Mirtazapine on Appetite in Advanced Cancer Patients
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Psychophysical Studies of Cancer Therapy Pain
Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer
Simulation-Free Celiac Plexus Pain Ablation Using Stereotactic Body Radiotherapy in Patients With Cancer-Related Celiac Pain
Resilience-Building for Advance Care Planning
Caregivers-Patients Support Coping With Advanced-Cancer (CASA) Intervention
A Study of PHN-012 in Patients With Advanced Solid Tumors
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Phase 1/2 Study of UI-102 in Selected Advanced Cancers
A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
Trial of Spiritual Care Interventions for Patients With Cancer
Identifying Family Members in Need of Support While Caregiving and After Loss
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors
Meaning-Centered Counseling for Chinese Patients Who Are Being Treated for Advanced Cancer
A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)
A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors